Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Rayatzadeh, Hussein ^a   Tan, Alex ^a   Chan, Raymond H ^a   Patel, Shalin J ^a   Hauser, Thomas H ^a   Ngo, Long ^a   Shaw, Jaime L ^a   Hong, Susie N ^a   Zimetbaum, Peter ^a   Buxton, Alfred E ^a   Josephson, Mark E ^a   Manning, Warren J ^a,b   Nezafat, Reza ^a,c  

^a Department of Medicine ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular magnetic resonance; Implantable cardioverter defibrillator; Late gadolinium enhancement; Scar heterogeneity

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIMARY PREVENTION; PRIORITY JOURNAL; SCAR; SUDDEN CARDIAC DEATH; ARRHYTHMIAS, CARDIAC; CARDIOVERSION; COMPLICATION; DEATH, SUDDEN, CARDIAC; DEVICES; DISEASE FREE SURVIVAL; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; PROSTHESIS FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; ARRHYTHMIAS, CARDIAC; CICATRIX; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84875937035     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-31     Document Type: Article

References (35)

1. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, Vickers C, Dogra V, Daya M, et al. J Am Coll Cardiol 2004 44 1268 75 10.1016/j.jacc.2004. 06.029 15364331
2. Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, et al. New England Journal of Medicine 2004 350 2151 8 10.1056/NEJMoa033088 15152060
3. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, et al. N Engl J Med 2005 352 225 37 10.1056/NEJMoa043399 15659722
4. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, et al. Circulation 2008 117 350 408 18483207
5. Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, et al. New Engl J Med 2005 352 225 37 10.1056/NEJMoa043399 15659722
6. Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease: Lessons From the MUSTT Study. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN, J Am Coll Cardiol 2007 50 1150 7 10.1016/j.jacc.2007.04.095 17868806
7. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, Degroot PJ, J Am Coll Cardiol 2005 46 310 6 10.1016/j.jacc.2005.03.060 16022960
8. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, O'Toole MF, Page RL, Reynolds M, Josephson ME, Circulation 2004 110 766 9 10.1161/01.CIR.0000139311.32278.32 15289365
9. Characterization of the electroanatomic substrate for monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy. Hsia HH, Marchlinski FE, Pacing Clin Electrophysiol 2002 25 1114 27 10.1046/j.1460-9592. 2002.01114.x 12164454
10. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. Wu TJ, Ong JJ, Hwang C, Lee JJ, Fishbein MC, Czer L, Trento A, Blanche C, Kass RM, Mandel WJ, et al. J Am Coll Cardiol 1998 32 187 96 10.1016/S0735-1097(98)00184-3 9669269
11. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, Meininger GR, Roguin A, Calkins H, Tomaselli GF, et al. Circulation 2005 112 2821 5 10.1161/CIRCULATIONAHA.105.549659 16267255
12. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ, J Am Coll Cardiol 2011 57 821 8 10.1016/j.jacc.2010.06.062 21310318
13. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ, Lancet 2001 357 21 8 10.1016/S0140-6736(00)03567-4 11197356
14. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM, Circulation 2002 106 2322 7 10.1161/01.CIR.0000036368. 63317.1C 12403661
15. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, et al. Circulation 2007 115 2006 14 10.1161/CIRCULATIONAHA.106.653568 17389270
16. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ, Am J Cardiol 2002 90 29 34 10.1016/S0002-9149(02)02381-0 12088775
17. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. Grimm W, Hoffmann JJ, Muller HH, Maisch B, J Am Coll Cardiol 2002 39 780 7 10.1016/S0735-1097(01)01822-8 11869841
18. Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. Hook BG, Marchlinski FE, J Am Coll Cardiol 1991 17 985 90 10.1016/0735-1097(91)90885-D 1999638
19. ICD data storage: value in arrhythmia management. Marchlinski FE, Gottlieb CD, Sarter B, Finkle J, Hook B, Callans D, Schwartzman D, Pacing Clin Electrophysiol 1993 16 527 34 10.1111/j.1540-8159.1993.tb01620.x 7681952
20. Use of bipolar recordings from patch-patch and rate sensing leads to distinguish ventricular tachycardia from supraventricular rhythms in patients with implantable cardioverter defibrillators. Callans DJ, Hook BG, Marchlinski FE, Pacing Clin Electrophysiol 1991 14 1917 22 10.1111/j.1540-8159.1991.tb02790. x 1721199
21. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, New Engl J Med 2002 346 877 83 10.1056/NEJMoa013474 11907286
22. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. Stevenson WG, Friedman PL, Sager PT, Saxon LA, Kocovic D, Harada T, Wiener I, Khan H, J Am Coll Cardiol 1997 29 1180 9 10.1016/S0735-1097(97)00065-X 9137211
23. Sudden cardiac death. Zipes DP, Wellens HJ, Circulation 1998 98 2334 51 10.1161/01.CIR.98.21.2334 9826323
24. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 1992 2002 10.1161/01.CIR.100.19.1992 10556226
25. Coronary magnetic resonance angiography for the detection of coronary stenoses. Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, Langerak SE, Weber OM, Pedersen EM, Schmidt M, et al. N Engl J Med 2001 345 1863 9 10.1056/NEJMoa010866 11756576
26. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models. de Haan S, Meijers TA, Knaapen P, Beek AM, van Rossum AC, Allaart CP, Heart 2011
27. Determinants of postinfarction ventricular tachycardia. Crawford T, Cowger J, Desjardins B, Kim HM, Good E, Jongnarangsin K, Oral H, Chugh A, Pelosi F, Morady F, Bogun F, Circ Arrhythm Electrophysiol 2010 3 624 631 10.1161/CIRCEP.110.945295 20937722
28. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ, J Am Coll Cardiol 2005 45 1104 1108 10.1016/j.jacc.2004.12.057 15808771
29. Shades of gray in cardiac magnetic resonance images of infarcted myocardium: can they tell us what we'd like them to? Klocke FJ, Wu E, Lee DC, Circulation 2006 114 8 10 10.1161/CIRCULATIONAHA.106.636456 16818828
30. Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. Hsu LY, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE, J Magn Reson Imaging 2006 23 298 308 10.1002/jmri.20496 16450367
31. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Schelbert EB, Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, Aletras AH, Arai AE, Circ Cardiovasc Imaging 2010 3 743 752 10.1161/CIRCIMAGING.108.835793 20847191
32. Human histopathology of electroanatomic mapping after cooled-tip radiofrequency ablation to treat ventricular tachycardia in remote myocardial infarction. Deneke T, Muller KM, Lemke B, Lawo T, Calcum B, Helwing M, Mugge A, Grewe PH, J Cardiovasc Electrophysiol 2005 16 1246 1251 10.1111/j.1540-8167. 2005.40826.x 16302912
33. Effect of early reperfusion on use of triphenyltetrazolium chloride to differentiate viable from non-viable myocardium in area of risk. Freeman I, Grunwald AM, Robin B, Rao PS, Bodenheimer MM, Cardiovasc Res 1990 24 109 114 10.1093/cvr/24.2.109 1691681
34. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, et al. Circ Cardiovasc Imaging 2009 2 183 190 10.1161/CIRCIMAGING.108. 826529 19808591
35. The Extent of Left Ventricular Scar Quantified by Late Gadolinium Enhancement MRI Is Associated with Spontaneous Ventricular Arrhythmias in Patients with Coronary Artery Disease and Implantable Cardioverter Defibrillators. Scott PA, Morgan JM, Carroll N, Murday DC, Roberts PR, Peebles CR, Harden SP, Curzen NP, Circ Arrhythm Electrophysiol 2011